Skip to main content
Uncategorized

ADE Gestió Sodical joins the shareholders of Fénix Biotech

By 28 de September de 2010November 18th, 2020No Comments
< Back to news
 28.09.2010

ADE Gestió Sodical joins the shareholders of Fénix Biotech

Fénix Biotech, created by the biotechs Genetrix and Advancell –based at the Barcelona Science Park- has made public the incorporation to its social capital of ADE Gestión Sodical SGECR, a Management Association of Venture Capital Companies in which ADE Financiación and the Caixes d'Estalvis de Castilla y León savings banks hold a stake.

The investment has been carried out by means of an investment fund from ADE Financiación Capital Semilla FCR’ in the amount of 180,000 Euros, which values the total worth of the company at 3 MM Euros. With this capital, Fénix Biotech will boost its research on the development of therapeutic solutions for the treatment of monogenic diseases.

For more information